Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2025 16:58 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases,...
October 19, 2022 09:35 ET | Source: CMI

Global Hyperbaric Oxygen Therapy (HBOT) Devices Market to Surpass US$ 4,881.5 Million by 2030, Says Coherent Market Insights (CMI)

Seattle, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global hyperbaric oxygen therapy (HBOT) devices market is estimated to be valued at US$ 2,891.5 million in 2022...
April 08, 2021 18:58 ET | Source: BioAegis Therapeutics

Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases

Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression. Gelsolin is non-immunosuppressive unlike current treatments to quell...